Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Bedrock Bedrock +19.53%
#4 Cysic Cysic +19.17%
#5 Fabric Protocol Fabric Protocol +15.42%
#6 Perle Perle +8.92%
#7 Nockchain Nockchain +8.81%
#8 Arowana Arowana +8.41%
#9 Velvet Velvet +6.80%
#10 stake.link stake.link +6.79%
Coin of the day
EXOD EXOD
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
BioVaxys Technology Corp. BioVaxys Technology Corp.

BioVaxys Technology Corp.

BIOV
Pozycja w akcjach #37710
BioVaxys Technology Corp. is a clinical-stage biotechnology company... BioVaxys Technology Corp. is a clinical-stage biotechnology company specializing in the development of vaccine platforms designed to combat both viral infections and cancer. The company's pipeline includes BVX-0320, a single-strain vaccine for SARS-CoV-2, and BVX-0918A, an experimental haptenized tumor cell vaccine targeting ovarian cancer. Additionally, BioVaxys offers CoviDTH, an immunodiagnostic tool to detect immune system activity in SARS-CoV-2-exposed patients. Further initiatives encompass Papilocare, aimed at HPV-dependent cervical lesions, along with BVX-0918C for cervical cancer, the HPV viral vaccine BVX-0204, and BVX-0121, a multivalent SARS-CoV-2 vaccine. BioVaxys has established strategic collaborations, such as a bioproduction agreement with WuXi Biologics Limited to manufacture SARS-CoV-2 s-proteins crucial for BVX-0320 and CoviDTH. It also holds a research partnership with The Ohio State University, Wexner School of Medicine, focusing on BVX-0320, and has engaged Bioanalytical Systems, Inc. for preclinical toxicology evaluations of its CoviDTH immunodiagnostic. The company is headquartered in Vancouver, Canada.
Cena akcji
$0.05137558
Ostatnia synchronizacja: 2026-06-01
Kapitalizacja rynkowa
$1.50M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-71.60%
Kraj
CA
Handel BioVaxys Technology Corp. (BIOV)

Kategoria

Healthcare
Historia ceny akcji dla BioVaxys Technology Corp. (BIOV)
Najwyższa cena zamknięcia: $0.05 dnia 2026-06-01

Najniższa cena zamknięcia: $0.43 dnia 2018-11-01
Historia cen akcji firmy BioVaxys Technology Corp. od 2018 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -17.58%
2025 -62.92%
2024 170.02%
2023 -84.82%
2022 -43.00%
2021 -5.87%
2020 507.75%
2019 -27.50%
2018 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE